RFC-1 is responsible for the intracellular transport of the chemotherapeutic drug methotrexate, and cancerous cells of DS subjects with extra copies of chromosome 21 are at increased risk of methotrexate-associated toxicity due to an increased intracellular transport of the drug via RFC-1 [33]. This evidence concerns the gene RFC1 and Dravet syndrome.